DD
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
L2 is tightly controlled
Stellar
CEO tweeted we will be hearing re: approval “quite soon.”
Just in case you didn’t see the details: https://www.sec.gov/Archives/edgar/data/1645260/000149315220005504/form6-k.htm
Agreed VISL
Big tweet “expecting” FDA approval “quite soon”
Lots of approvals on PCR tests, and our partners at 3D Med are in the process with the FDA already, expecting approval hopefully quite soon. We’re also bringing antibody point of care testing to market. This combination approach is what we intend to market to providers.
— Gerald Commissiong (@G_Commish) April 1, 2020
“Todos Medical (OTCMKTS: TOMDF) both have a blood test with a 90% sensitivity than can be done between 2 to 10 minutes. Todos Medical has stated that its supplier can supply 300,000 test kits daily. The quicker these Chinese approved test kits get validated the more people that can be tested. They key is to pick the development team that can validate the test as quickly as possible. Based on the announcement Todos has a decisive lead in experience with Rao Mulpuri who is an expert in genomics and has commercialized a number of molecular diagnostics before.”
https://insiderfinancial.com/coronavirus-secondary-stocks-to-watch/179746/
Looks like that handle breakout is nearing
Very substantial 6K and sweet set up.
Covid POC tests are going to be needed for years
They are starting to really like TOMDF with POC Covid tests and massive distribution channels
Good COVID testing news here yesterday! Looking for a continuation
Agreed
That is our plan - we are working on this now. Not in a few weeks
— Gerald Commissiong (@G_Commish) March 30, 2020
CEO tweeted that they are working on FDA approval “now not in a few weeks”
I believe we will have new highs incoming
Looking good this morning!
Lol. I read your message to mean you have no opinion here
Emor just put out news
don't you think they would have realized it already if it was legit
We got to be getting close
On March 6, 2020, Inspyr Therapeutics, Inc. (“Company”) sold an aggregate of $250,000 of senior convertible debentures (“Debentures”) for cash to existing accredited institutional investors of the Company (the “Offering”).
The Debentures issued (i) are non-interest bearing, (ii) have a maturity date of July 16, 2020 and (iii) are convertible into shares of common stock (“Common Stock”) of the Company at the election of the Investor at any time, subject to a beneficial ownership limitation of 4.99% which may be increased to 9.99% by the holder upon 61 days’ notice. The Debentures will have a conversion price equal to the lesser of (i) $0.33 and (ii) 85% of the lesser of (a) the volume weighted average price on the trading day immediately preceding a conversion date and (b) the volume weighted average price on a conversion date.
The Debentures also contain provisions providing for an adjustment in the event of stock splits or dividends, and fundamental transactions. The Investors will also have the right to participate in subsequent rights offerings and pro rata distributions. Additionally, the Debentures contain anti-dilution protection in the event of subsequent equity sales at a price that is lower than the then applicable conversion price until such time that the Debentures are no longer outstanding. Additionally, the Company has the option to redeem some or all of the Debentures for cash upon notice of twenty (20) trading days provided certain conditions are met by the Company as more fully described in the Debentures.
Furthermore, without the approval of the Debenture holders holding at least 67% of the then outstanding principal amount of the Debentures, the Company may not (i) amend its charter documents in any manner that adversely affects the rights of any Investor, (ii) repay or repurchase or acquire shares of its Common Stock, (iii) repay, repurchase, or acquire certain indebtedness, or (iv) pay cash dividends or distributions on any equity securities of the Company.
The securities offered have not been registered under the Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements. This current report shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state.
The foregoing summary of the Debentures is qualified in its entirety by reference to the full text of such document, a copy of the form of which is attached hereto as Exhibit 10.01, and which is incorporated herein in its entirety by reference.
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
The information set forth above in Item 1.01 of this current report on Form 8-K is incorporated herein by reference in its entirety.
Item 3.02 Unregistered Sale of Equity Securities.
The information set forth above in Item 1.01 of this current report on Form 8-K is incorporated herein by reference in its entirety.
Item 9.01 Financial Statement and Exhibits.
Exhibit
No.
Description
10.01 Form of Senior Convertible Debenture
https://www.sec.gov/Archives/edgar/data/1421204/000121390020005591/ea119382-8k_inspyrtherape.htm
Nice news!
Chart intact? Buy time yet?
How’s it looking today, still thinking reversal setting up here?
.40 break imminent
30K on the bid
Power hour
FDA approval should be out ASAP. The need for kits is growing exponentially, especially in NY. Company communicates well as evidenced by 8K following PR
Good to know, meaning FDA approval is a guarantee. That news will put us over a dollar. FDA is clearing these quickly, to get them out and NY is the #1 hotbed
Multi day runner here
How much more dilution is left?
Backs to 0013s?
Ask gonna start stacking if we don’t slap it. I added 200K mid 002s